cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
89bio Inc
2 own
6 watching
Current Price
$11.59
$-0.5
(-4.14%)
logo-etnb
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
505.61M
52-Week High
52-Week High
12.95
52-Week Low
52-Week Low
2
Average Volume
Average Volume
0.51M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization505.61M
icon52-Week High12.95
icon52-Week Low2
iconAverage Volume0.51M
iconDividend Yield--
iconP/E Ratio--
What does the 89bio Inc do?
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.
Read More
How much money does 89bio Inc make?
News & Events about 89bio Inc.
Globe Newswire
2 months ago
- New analysis of cohort 7 data using a three-reader pathologist panel showed that 6/19 patients scored as having fibrosis stage 4 at baseline (putative F4); excluding these patients resulted in higher histological response rates in the patients with F2-F3 fibrosis than previously reported - SAN ...
PR Newswire
3 months ago
Thinking about buying stock in Purecycle Technologies, Sellas Life Sciences, Nurix Therapeutics, Pineapple Energy, or 89bio? Thinking about buying stock in Purecycle Technologies, Sellas Life Sciences, Nurix Therapeutics, Pineapple Energy, or 89bio? PR Newswire NEW YORK, Oct. 21, 2022 NEW YORK...
PR Newswire
4 months ago
Thinking about buying stock in Caladrius Biosciences, Timber Pharmaceuticals, 89Bio, Alaunos Therapeutics, or SoFi Technologies? Thinking about buying stock in Caladrius Biosciences, Timber Pharmaceuticals, 89Bio, Alaunos Therapeutics, or SoFi Technologies? PR Newswire NEW YORK, Sept. 14, 2022 NEW...
PR Newswire
4 months ago
Thinking about buying stock in Akero Therapeutics, Planet Labs, Kaspien Holdings, Neurobo Pharmaceuticals, or 89Bio? Thinking about buying stock in Akero Therapeutics, Planet Labs, Kaspien Holdings, Neurobo Pharmaceuticals, or 89Bio? PR Newswire NEW YORK, Sept. 13, 2022 NEW YORK, Sept. 13, 2022...
Globe Newswire
5 months ago
-Results featured in a late-breaking oral presentation- -Treatment with pegozafermin demonstrated consistent and significant benefit in triglyceride (TG) reduction as well as improvements in liver fat and glycemic control- -Positive data support the advancement into a Phase 3 trial in SHTG- SAN ...
Frequently Asked Questions
Frequently Asked Questions
What is 89bio Inc share price today?
plus_minus_icon
Can Indians buy 89bio Inc shares?
plus_minus_icon
How can I buy 89bio Inc shares from India?
plus_minus_icon
Can Fractional shares of 89bio Inc be purchased?
plus_minus_icon
What are the documents required to start investing in 89bio Inc stocks?
plus_minus_icon
What is today’s traded volume of 89bio Inc?
plus_minus_icon
What is today’s market capitalisation of 89bio Inc?
plus_minus_icon
What is the 52-Week High and Low Range of 89bio Inc?
plus_minus_icon
What percentage is 89bio Inc down from its 52-Week High?
plus_minus_icon
What percentage is 89bio Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$11.59
$-0.5
(-4.14%)
logo-etnb
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00